Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-10 4:00 pm Sale |
2025-03-31 | 13G | ANI Pharmaceuticals, Inc. ANIP |
MILLENNIUM MANAGEMENT LLC | 818,341 3.800% |
-272,662 (-24.99%) |
Filing History |
| 2025-03-13 8:50 pm Sale |
2025-03-11 | 13D | ANI Pharmaceuticals, Inc. ANIP |
Meridian Venture Partners II GP, L.P. ("GP") | 1,184,570 5.400% |
-260,000 (-18.00%) |
Filing History |
| 2025-01-21 4:04 pm Purchase |
2025-01-14 | 13G | ANI Pharmaceuticals, Inc. ANIP |
MILLENNIUM MANAGEMENT LLC | 1,091,003 5.200% |
1,091,003 (New Position) |
Filing History |
| 2024-11-13 4:30 pm Sale |
2024-09-30 | 13G | ANI Pharmaceuticals, Inc. ANIP |
Rubric Capital Management LP | 56,671 0.270% |
-1,068,329 (-94.96%) |
Filing History |
| 2024-03-14 07:30 am Sale |
2024-03-12 | 13D | ANI Pharmaceuticals, Inc. ANIP |
Meridian Venture Partners II GP, L.P. ("GP") | 1,444,570 6.900% |
-232,855 (-13.88%) |
Filing History |
| 2024-02-13 4:58 pm Purchase |
2023-12-29 | 13G | ANI Pharmaceuticals, Inc. ANIP |
The Vanguard Group | 1,288,972 6.310% |
1,288,972 (New Position) |
Filing History |
| 2024-02-12 06:06 am Purchase |
2023-12-31 | 13G | ANI Pharmaceuticals, Inc. ANIP |
Rubric Capital Management LP | 1,125,000 5.510% |
1,125,000 (New Position) |
Filing History |
| 2024-01-23 4:13 pm Purchase |
2023-12-31 | 13G | ANI Pharmaceuticals, Inc. ANIP |
BLACKROCK INC BLK |
2,524,660 12.400% |
541,423 (+27.30%) |
Filing History |
| 2024-01-17 07:45 am Sale |
2023-12-18 | 13D | ANI Pharmaceuticals, Inc. ANIP |
Esjay LLC | 985,027 4.800% |
-50,000 (-4.83%) |
Filing History |
| 2023-12-18 5:18 pm Sale |
2023-12-14 | 13D | ANI Pharmaceuticals, Inc. ANIP |
Meridian Venture Partners II GP, L.P. ("GP") | 1,677,425 8.200% |
-190,855 (-10.22%) |
Filing History |
| 2023-12-05 4:30 pm Sale |
2023-11-17 | 13D | ANI Pharmaceuticals, Inc. ANIP |
Esjay LLC | 1,035,027 5.070% |
-311,053 (-23.11%) |
Filing History |
| 2023-08-17 6:22 pm Sale |
2023-08-16 | 13D | ANI Pharmaceuticals, Inc. ANIP |
Meridian Venture Partners II GP, L.P. ("GP") | 1,868,280 9.200% |
-200,000 (-9.67%) |
Filing History |
| 2023-01-26 08:52 am Unchanged |
2022-12-31 | 13G | ANI Pharmaceuticals, Inc. ANIP |
BLACKROCK INC BLK |
1,983,237 11.400% |
0 (Unchanged) |
Filing History |
| 2023-01-20 09:43 am Purchase |
2022-12-31 | 13G | ANI Pharmaceuticals, Inc. ANIP |
BLACKROCK INC BLK |
1,983,237 11.400% |
296,624 (+17.59%) |
Filing History |
| 2022-12-12 4:00 pm Purchase |
2022-12-01 | 13D | ANI Pharmaceuticals, Inc. ANIP |
Meridian Venture Partners II GP, L.P. ("GP") | 2,068,280 11.800% |
2,068,280 (New Position) |
Filing History |
| 2022-03-02 4:30 pm Purchase |
2021-11-19 | 13D | ANI Pharmaceuticals, Inc. ANIP |
Esjay LLC | 1,346,080 8.040% |
1,346,080 (New Position) |
Filing History |
| 2022-02-07 4:41 pm Purchase |
2021-12-31 | 13G | ANI Pharmaceuticals, Inc. ANIP |
BLACKROCK INC BLK |
1,686,613 11.800% |
97,385 (+6.13%) |
Filing History |
| 2021-01-26 6:52 pm Purchase |
2020-12-31 | 13G | ANI Pharmaceuticals, Inc. ANIP |
BLACKROCK INC BLK |
1,589,228 12.900% |
41,479 (+2.68%) |
Filing History |